Hemispherx Analysis of New Data on Protection from Pulmonary Damage Associated with Infection by Highly Pathogenic Influenza Virus

….. Joint Project with Viroclinics Biosciences, Rotterdam

Philadelphia, PA, Wednesday, January 22, 2014: Hemispherx Biopharma (NYSE MKT: HEB), today announced that Dr. William M. Mitchell of Vanderbilt University presented a research paper on January 21, 2014 at the Keystone Symposia Conference on Pathogenesis of Respiratory Viruses entitled "Protection from Pulmonary Tissue Damage Associated with Infection of Cynomolgus Macaques by Highly Pathogenic Avian Influenza Virus (H5N1) by Low Dose Natural Human IFN-